The new $467 million includes $400 million in royalties for the Pfizer-BioNTech vaccine from 2020 through 2023.

Morgan Stanley analyst Terence Flynn notes that BioNTech (BNTX) announced last week that it had reached a settlement agreement with the National Institutes of Health and University of Pennsylvania ...

University of Pennsylvania will receive $467 million from BioNTech as part of a settlement in a lawsuit over COVID-19 vaccine royalties, writes John George ...

The university filed a lawsuit against BioNTech four months ago, claiming that the company licensed vaccine technology ...

plus another $15 million to fund BioNTech and University of Pennsylvania vaccine alliance research for another three years as part of the settlement. Finally, the company will contribute $52 million ...

In Review 805 articles and counting2,837 new Instagram followers1,771 new Bluesky followers It was quite a year. Join us in ...

France reports bird flu on two farms, losing disease-free status Healthcare & Pharmaceuticalscategory· December 31, 2024 BioNTech has entered into two separate settlement agreements with the U.S ...

Novartis must face claims it paid kickbacks to promote MS drug, US appeals court rules Legalcategory· December 27, 2024 BioNTech has entered into two separate settlement agreements with the U.S ...

In 2009, Pfizer faced more than $2 billion in legal settlement payments over marketing ... vaccine approved – via its collaboration with BioNTech – it feels like we're only on the cusp of ...